Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Big FDA review coming this July. Here's what athletes and patients should know about BPC 157, TB 500, and the broader peptide conversation. Always speak with your physician before starting any new protocol. #bpc157 #